Stay updated with breaking news from Global Generics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com downgraded shares of Dr. Reddy’s Laboratories (NYSE:RDY – Free Report) from a strong-buy rating to a buy rating in a report published on Thursday. Separately, Barclays lifted their price objective on shares of Dr. Reddy’s Laboratories from $80.00 to $81.00 and gave the company an overweight rating in a research note on Wednesday, May […]
StockNews.com cut shares of Dr. Reddy’s Laboratories (NYSE:RDY – Free Report) from a strong-buy rating to a buy rating in a research report report published on Thursday morning. Separately, Barclays lifted their price target on shares of Dr. Reddy’s Laboratories from $80.00 to $81.00 and gave the company an overweight rating in a research note […]
Panagora Asset Management Inc. grew its holdings in shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) by 47.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 119,794 shares of the company’s stock after buying an additional 38,602 shares during […]
Summit Global Investments boosted its holdings in Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) by 13.4% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 35,348 shares of the company’s stock after acquiring an additional 4,189 shares during the period. Summit Global Investments’ holdings in Dr. Reddy’s Laboratories were worth $2,460,000 as […]
Summit Global Investments increased its holdings in shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) by 13.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 35,348 shares of the company’s stock after buying an additional 4,189 shares during the […]